{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:28:48Z","timestamp":1772166528217,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1186\/s13099-014-0034-0","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T08:00:35Z","timestamp":1408435235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients"],"prefix":"10.1186","volume":"6","author":[{"given":"Robyn","family":"Nagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Bielefeldt-Ohmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Traub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"issue":"4","key":"34_CR1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/CMR.00022-08","volume":"21","author":"KS Tan","year":"2008","unstructured":"Tan KS: New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008, 21 (4): 639-665. 10.1128\/CMR.00022-08.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"34_CR2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00436-011-2626-7","volume":"110","author":"DEM-FW Jimenez-Gonzalez","year":"2012","unstructured":"Jimenez-Gonzalez DEM-FW, Reues-Gordillo J, Ramirez-Mirnada M, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A, Olivo-Diaz A, Maravilla P: Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res. 2012, 110 (3): 1269-1275. 10.1007\/s00436-011-2626-7.","journal-title":"Parasitol Res"},{"issue":"11","key":"34_CR3","doi-asserted-by":"crossref","first-page":"e15484","DOI":"10.1371\/journal.pone.0015484","volume":"5","author":"F Dogruman-Al","year":"2010","unstructured":"Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altinbas A: Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS\/IBD Patients in Ankara, Turkey. PLoS One. 2010, 5 (11): e15484-10.1371\/journal.pone.0015484.","journal-title":"PLoS One"},{"issue":"10","key":"34_CR4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2982.2007.01001.x","volume":"19","author":"DA Drossman","year":"2007","unstructured":"Drossman DA: Introduction. The Rome Foundation and Rome III. Neurogastroenterol Motil. 2007, 19 (10): 783-786. 10.1111\/j.1365-2982.2007.01001.x.","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"34_CR5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1365-2036.2003.t01-1-01736.x","volume":"18","author":"JMFM Inadomi","year":"2003","unstructured":"Inadomi JMFM, Bjorkman D: The economic impact of irritable bowel syndrome. Aliment Pharmacol Therapeut. 2003, 18 (7): 671-682. 10.1046\/j.1365-2036.2003.t01-1-01736.x.","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"14","key":"34_CR6","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.3748\/wjg.v20.i14.3976","volume":"20","author":"JKBA Beatty","year":"2014","unstructured":"Beatty JKBA, Buret AG: Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014, 20 (14): 3976-3985. 10.3748\/wjg.v20.i14.3976.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"34_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrgastro.2014.40","volume":"11","author":"S Collins","year":"2014","unstructured":"Collins S: A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014, 11 (8): 497-505. 10.1038\/nrgastro.2014.40.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/apt.12728","volume":"39","author":"H DuPont","year":"2014","unstructured":"DuPont H: Review article: evidence for the role of gut microbiota in irritable bowel syndorme and its potential influence on therapeutic targets. Aliment Pharmacol Ther. 2014, 39: 1033-1042. 10.1111\/apt.12728.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1099\/mic.0.043257-0","volume":"156","author":"A de Salonen","year":"2010","unstructured":"de Salonen A, Vos WM, Palva A: Gastrointestinal microbiota in irritable bowel syndrome:present state and perspectives. Microbiology. 2010, 156: 3205-3215. 10.1099\/mic.0.043257-0.","journal-title":"Microbiology"},{"key":"34_CR10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.12080","volume":"36","author":"JM Matricon","year":"2012","unstructured":"Matricon JM, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D: Review article:associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012, 36: 1009-1031. 10.1111\/apt.12080.","journal-title":"Aliment Pharmacol Ther"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","volume":"171","author":"M LA Bruewer","year":"2003","unstructured":"LA Bruewer M, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A: Proinflammatory cytokines disrupt epithelial barrier funciton by apoptosis-independent mechanisms. J Immunol. 2003, 171: 6164-6172. 10.4049\/jimmunol.171.11.6164.","journal-title":"J Immunol"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/gutjnl-2011-300775","volume":"61","author":"NMK Steck","year":"2014","unstructured":"Steck NMK, Schermann M, Haller D: Bacterial proteases in IBD and IBS. Gut. 2014, 61: 1610-1618. 10.1136\/gutjnl-2011-300775.","journal-title":"Gut"},{"issue":"5","key":"34_CR13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.2007.140210","volume":"57","author":"K Gecse","year":"2008","unstructured":"Gecse K, Roka R, Ferrier L, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztoczy A, Izbeki F, Fioramonti J, Wittmann T, Bueno L: Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic luminal factor impairing colonic permeability and sensitivity. Gut. 2008, 57 (5): 591-599. 10.1136\/gut.2007.140210.","journal-title":"Gut"},{"issue":"3","key":"34_CR14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/EC.00371-07","volume":"7","author":"MK Puthia","year":"2008","unstructured":"Puthia MK, Lu J, Tan KS: Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot Cell. 2008, 7 (3): 435-443. 10.1128\/EC.00371-07.","journal-title":"Eukaryot Cell"},{"issue":"7","key":"34_CR15","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1128\/IAI.00328-06","volume":"74","author":"MK Puthia","year":"2006","unstructured":"Puthia MK, Sio SWS, Lu J, Tan KSW: Blastocystis ratti Induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun. 2006, 74 (7): 4114-4123. 10.1128\/IAI.00328-06.","journal-title":"Infect Immun"},{"issue":"5","key":"34_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s00436-005-1461-0","volume":"97","author":"MK Puthia","year":"2005","unstructured":"Puthia MK, Vaithilingam A, Lu J, Tan KS: Degradation of human secretory immunoglobulin A by Blastocystis. Parasitol Res. 2005, 97 (5): 386-389. 10.1007\/s00436-005-1461-0.","journal-title":"Parasitol Res"},{"issue":"2","key":"34_CR17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00436-008-1203-1","volume":"104","author":"H Mirza","year":"2009","unstructured":"Mirza H, Tan KS: Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol Res. 2009, 104 (2): 355-361. 10.1007\/s00436-008-1203-1.","journal-title":"Parasitol Res"},{"issue":"3","key":"34_CR18","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1074\/jbc.M109.049064","volume":"285","author":"B Wu","year":"2010","unstructured":"Wu B, Yin J, Texier C, Roussel M, Tan KS: Blastocystis legumain is localized on the cell surface, and specific inhibition of its activity implicates a pro-survival role for the enzyme. J Biol Chem. 2010, 285 (3): 1790-1798. 10.1074\/jbc.M109.049064.","journal-title":"J Biol Chem"},{"issue":"5","key":"34_CR19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00436-010-1761-x","volume":"106","author":"J Yakoob","year":"2010","unstructured":"Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R: Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res. 2010, 106 (5): 1033-1038. 10.1007\/s00436-010-1761-x.","journal-title":"Parasitol Res"},{"key":"34_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/JCM.02541-12","volume":"51","author":"CR Stensvold","year":"2013","unstructured":"Stensvold CR: Comparison of Sequencing (Barcode Region) and Sequence-Tagged-Site PCR for Blastocystis Sub-typing. J Clin Microbiol. 2013, 51: 190-194. 10.1128\/JCM.02541-12.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"34_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MCG.0b013e3181bb86ba","volume":"44","author":"CR Stensvold","year":"2009","unstructured":"Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ: Eradication of Blastocystis carriage with antimicrobials: reality or delusion?. J Clin Gastroenterol. 2009, 44 (2): 85-90. 10.1097\/MCG.0b013e3181bb86ba.","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"34_CR22","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1445-5994.2011.02626.x","volume":"42","author":"R Nagel","year":"2012","unstructured":"Nagel R, Cuttell L, Stensvold CR, Mills PC, Bielefeldt-Ohmann H, Traub RJ: Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J. 2012, 42 (11): 1187-1195. 10.1111\/j.1445-5994.2011.02626.x.","journal-title":"Intern Med J"},{"issue":"4018","key":"34_CR23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/158625b0","volume":"158","author":"DR Jones","year":"1946","unstructured":"Jones DR: A medium for investigating the breakdown of pectin by bacteria. Nature. 1946, 158 (4018): 625-10.1038\/158625b0.","journal-title":"Nature"},{"issue":"4","key":"34_CR24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00436-007-0808-0","volume":"102","author":"KH Wong","year":"2008","unstructured":"Wong KH, Ng GC, Lin RT, Yoshikawa H, Taylor MB, Tan KS: Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res. 2008, 102 (4): 663-670. 10.1007\/s00436-007-0808-0.","journal-title":"Parasitol Res"},{"issue":"12","key":"34_CR25","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/bioinformatics\/17.12.1244","volume":"17","author":"S Kumar","year":"2001","unstructured":"Kumar S, Tamura K, Jakobsen IB, Nei M: MEGA2:Molecular Evolutionary Genetics Analysis software. Bioinformatics. 2001, 17 (12): 1244-1245. 10.1093\/bioinformatics\/17.12.1244.","journal-title":"Bioinformatics"},{"key":"34_CR26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1099\/jmm.0.065508-0","volume":"63","author":"T Roberts","year":"2014","unstructured":"Roberts T, Ellis J, Harkness J, Marriott D, Starl D: Treatment failure in patients with chronic Blastocystis infection. J Med Microbiol. 2014, 63: 252-257. 10.1099\/jmm.0.065508-0.","journal-title":"J Med Microbiol"},{"key":"34_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00436-012-2860-7","volume":"111","author":"TK LA Dunn","year":"2012","unstructured":"LA Dunn TK, Vanelle P, Juspin T, Crozet MD, Terme T, Upcroft P, Upcroft JA: Development of metronidazole-resistant lines of Blastocystis spp. Parasitol Res. 2012, 111: 441-450. 10.1007\/s00436-012-2860-7.","journal-title":"Parasitol Res"},{"issue":"2","key":"34_CR28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.00900-10","volume":"55","author":"H Mirza","year":"2010","unstructured":"Mirza H, Teo JDW, Upcroft J, Tan KSW: A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother. 2010, 55 (2): 637-648. 10.1128\/AAC.00900-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"34_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1550-7408.1983.tb02925.x","volume":"30","author":"CH Zierdt","year":"1983","unstructured":"Zierdt CH, Swan JC, Hosseini J: In vitro response of Blastocystis hominis to antiprotozoal drugs. J Protozool. 1983, 30 (2): 332-334. 10.1111\/j.1550-7408.1983.tb02925.x.","journal-title":"J Protozool"},{"issue":"7","key":"34_CR30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/PL00008533","volume":"86","author":"AA Vdovenko","year":"2000","unstructured":"Vdovenko AA, Williams JE: Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing. Parasitol Res. 2000, 86 (7): 573-581. 10.1007\/PL00008533.","journal-title":"Parasitol Res"},{"issue":"4","key":"34_CR31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/27.4.507","volume":"27","author":"LA Dunn","year":"1991","unstructured":"Dunn LA, Boreham PF: The in-vitro activity of drugs against Blastocystis hominis. J Antimicrob Chemother. 1991, 27 (4): 507-516. 10.1093\/jac\/27.4.507.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"34_CR32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","volume":"36","author":"KCFC Lamp","year":"1999","unstructured":"Lamp KCFC, Klutman NE, Lacy MK: Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials. Clin Pharmacokinet. 1999, 36 (5): 353-373. 10.2165\/00003088-199936050-00004.","journal-title":"Clin Pharmacokinet"},{"key":"34_CR33","first-page":"105","volume":"54","author":"CMJV Coyle","year":"2012","unstructured":"Coyle CMJV, Louis Weiss M, Herbert Tanowitz B: Blastocystis: to treat or not to treat. Clin Prac. 2012, 54: 105-107.","journal-title":"Clin Prac"},{"issue":"1","key":"34_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0022-3468(84)80023-8","volume":"19","author":"GGJ Menardi","year":"1984","unstructured":"Menardi GGJ: Bioavailability of oral antibiotics in children with short bowel syndrome. J Paediatr Surg. 1984, 19 (1): 84-86. 10.1016\/S0022-3468(84)80023-8.","journal-title":"J Paediatr Surg"},{"key":"34_CR35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.trstmh.2008.09.008","volume":"103","author":"RN dBM Davidson","year":"2008","unstructured":"Davidson RN dBM, Ritmeijer K: Paromomycin. Trans R Soc Trop Med Hyg. 2008, 103: 653-660. 10.1016\/j.trstmh.2008.09.008.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"34_CR36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10156-012-0496-2","volume":"19","author":"JMN van Hellemond","year":"2013","unstructured":"van Hellemond JMN, Koelewijn R, Wismans PJ, Genderen PJ: Is paromomycin the drug of choice for eradication of Blastocystisin adults?. J Infect Chemother. 2013, 19: 545-548. 10.1007\/s10156-012-0496-2.","journal-title":"J Infect Chemother"},{"issue":"42","key":"34_CR37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/499950","volume":"2006","author":"JA Adachi","year":"2006","unstructured":"Adachi JA, Rifaximin DH: A novel nonabsorbed rifamycin for gastrointestinal disorders. Clin Infect Dis. 2006, 2006 (42): 541-547. 10.1086\/499950.","journal-title":"Clin Infect Dis"},{"key":"34_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey W, Zakko S, Ringel Y, Yu J, Mareya S, Shaw A, Bortey E, Forbes W: Rifaximin therapy for patients with irritable bowel syndrome wihout constipation. NEJM. 2011, 364: 22-32. 10.1056\/NEJMoa1004409.","journal-title":"NEJM"},{"issue":"5","key":"34_CR39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1179\/joc.1999.11.5.391","volume":"11","author":"M Amenta","year":"1999","unstructured":"Amenta M, Dalle Nogare ER, Colomba C, Prestileo T, Di Lorenzo F, Fundaro S, Colomba A, Ferrieri A: Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections. J Chemother. 1999, 11 (5): 391-395. 10.1179\/joc.1999.11.5.391.","journal-title":"J Chemother"},{"key":"34_CR40","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.farmac.2003.11.015","volume":"59","author":"EA Gadkariem","year":"2004","unstructured":"Gadkariem EA, Belal F, Abounassif MA, El-Obeid HA, Ibrahim KE: Stability studies on diloxanide furoate: effect of pH, temperature, gastric and intestinal fluids. Il Farmaco. 2004, 59: 323-329. 10.1016\/j.farmac.2003.11.015.","journal-title":"Il Farmaco"},{"issue":"1","key":"34_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00436-007-0727-0","volume":"102","author":"LH Li","year":"2007","unstructured":"Li LH, Zhang XP, Lv S, Zhang L, Yoshikawa H, Wu Z, Steinmann P, Utzinger J, Tong X, Chen S, Zhou X: Cross-sectional surveys and subtype classification of human Blastocystis isolates from four epidemiological settings in China. Parasitol Res. 2007, 102 (1): 83-90. 10.1007\/s00436-007-0727-0.","journal-title":"Parasitol Res"},{"issue":"3","key":"34_CR42","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/JCM.01392-10","volume":"49","author":"P Poirier","year":"2011","unstructured":"Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, Livrelli V: Development and evaluation of a real-time PCR assay for detection and quantification of blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol. 2011, 49 (3): 975-983. 10.1128\/JCM.01392-10.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"34_CR43","first-page":"133","volume":"54","author":"Y Tasova","year":"2000","unstructured":"Tasova Y, Sahin B, Koltas S, Paydas S: Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama. 2000, 54 (3): 133-136.","journal-title":"Acta Med Okayama"},{"key":"34_CR44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00436-012-2830-0","volume":"111","author":"A Olivo-Diaz","year":"2012","unstructured":"Olivo-Diaz A, Romero-Valdovinos M, Gudino-Ramirez A, Reyes-Gordillo J, Jimenez-Gonzalez D, Ramirez-Miranda M, Martinez-Flores W, Martinez-Hernandez F, Flisser A, Maravilla P: Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol Res. 2012, 111: 487-491. 10.1007\/s00436-012-2830-0.","journal-title":"Parasitol Res"},{"key":"34_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.autrev.2013.10.005","volume":"13","author":"K Singh","year":"2014","unstructured":"Singh K, Chang C, Gershwin M: IgA deficiency and autoimmunity. Autoimmun Rev. 2014, 13: 163-177. 10.1016\/j.autrev.2013.10.005.","journal-title":"Autoimmun Rev"},{"key":"34_CR46","first-page":"101","volume":"4","author":"JW Stoop","year":"1969","unstructured":"Stoop JW, Zegers B, Sander P, Ballieux R: Serum immunoglobulin levels in healthy children and adults. Clin exp Immunol. 1969, 4: 101-112.","journal-title":"Clin exp Immunol"},{"key":"34_CR47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00436-009-1340-1","volume":"104","author":"K Suresh","year":"2009","unstructured":"Suresh K, Venilla GD, Tan TC, Rohela M: In vivo encystation of Blastocystis hominis. Parasitol Res. 2009, 104: 303-307. 10.1007\/s00436-009-1340-1.","journal-title":"Parasitol Res"},{"key":"34_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diagmicrobio.2007.06.003","volume":"59","author":"CR Stensvold","year":"2007","unstructured":"Stensvold CR, Arendrup M, Jespersgaard C, Molbak K, Nielsen H: Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diag Microbiol Inf Dis. 2007, 59: 303-307. 10.1016\/j.diagmicrobio.2007.06.003.","journal-title":"Diag Microbiol Inf Dis"},{"key":"34_CR49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4269\/ajtmh.1997.56.301","volume":"56","author":"R Hussain","year":"1997","unstructured":"Hussain R, Jaferi W, Zuberi A, Baqai R, Abrar N, Ahmed A, Zaman V: Significantly increased IgG2 subclass antibody levels in patients with irritable Bowel Syndrome. Am J Trop Med Hyg. 1997, 56: 301-306.","journal-title":"Am J Trop Med Hyg"},{"key":"34_CR50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00436-010-2156-8","volume":"108","author":"M Abou Gamra","year":"2011","unstructured":"Abou Gamra M, Elwakil H, El Deeb H, Khalifa K, Abd Elhafiz H: The potential us of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis. Parasitol Res. 2011, 108: 1139-1146. 10.1007\/s00436-010-2156-8.","journal-title":"Parasitol Res"},{"key":"34_CR51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","volume":"14","author":"T Gardner","year":"2001","unstructured":"Gardner T, Hill D: Treatment of giardiasis. Clin Microbiol Rev. 2001, 14: 114-128. 10.1128\/CMR.14.1.114-128.2001.","journal-title":"Clin Microbiol Rev"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-014-0034-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13099-014-0034-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-014-0034-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T23:36:13Z","timestamp":1565739373000},"score":1,"resource":{"primary":{"URL":"http:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-014-0034-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1186\/s13099-014-0034-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725232914.793501391","asserted-by":"object"}]},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"article-number":"34"}}